Equities

CorVel Corp

CRVL:NSQ

CorVel Corp

Actions
Health CareHealth Care Providers
  • Price (USD)316.64
  • Today's Change1.45 / 0.46%
  • Shares traded24.86k
  • 1 Year change+61.03%
  • Beta1.0900
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CorVel Corporation applies technology including artificial intelligence, machine learning and natural language processing to enhance the management of episodes of care and the related health care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies in managing workers' compensation and health, auto and liability services. Its customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients. The Company's services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. The Company offers a complete medical savings solution for all in-network and out-of-network medical bills. Its bill review services include coding review and re-bundling, reasonable and customary review, fee schedule analysis, preferred provider organization management, and repricing.

  • Revenue in USD (TTM)816.78m
  • Net income in USD78.02m
  • Incorporated1991
  • Employees4.87k
  • Location
    CorVel CorpSUITE 1020, 2010 MAIN STREEIRVINE 92614United StatesUSA
  • Phone+1 (949) 851-1473
  • Fax+1 (949) 851-1469
  • Websitehttps://www.corvel.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Astrana Health Inc1.59bn68.42m2.81bn1.80k39.614.0031.751.761.441.4433.5614.281.40--9.06884,350.005.847.096.779.3916.2818.304.186.36--11.800.480910.5421.1921.6834.4241.1689.42--
Concentra Group Holdings Parent Inc-100.00bn-100.00bn2.95bn8.90k--1.95----------11.98----------------------------0.2519--6.60--7.93------
Amedisys Inc2.29bn91.98m3.18bn19.00k34.742.8327.361.392.802.8069.6534.371.12--7.20120,506.604.487.826.0210.3944.0343.634.015.89--9.620.24820.000.5936.11-108.22--14.16--
Hims & Hers Health Inc1.07bn18.10m3.53bn1.05k217.419.77118.593.310.0750.0754.821.672.456.13225.781,020,207.004.16--5.21--82.19--1.70--2.30--0.00--65.49--64.15------
Surgery Partners Inc2.89bn-33.80m4.09bn10.50k--2.0915.871.42-0.2682-0.268222.9515.360.409527.915.94275,142.801.831.172.551.6326.9726.334.473.031.692.520.464--8.039.1478.21--17.41--
Select Medical Holdings Corp6.87bn258.77m4.59bn38.40k16.943.248.360.66782.082.0855.3110.890.8825--6.73178,985.004.304.195.345.4614.4213.984.875.11--3.960.678415.305.225.5753.0311.986.50--
Sotera Health Co1.10bn39.86m4.74bn3.00k119.4811.2123.794.320.14010.14013.881.490.35819.857.81366,062.001.31-0.8681.39-0.966455.1854.403.65-2.682.592.230.8459--4.547.06121.87--24.24--
Radnet Inc1.71bn9.92m4.96bn7.87k457.065.6328.502.900.14680.146824.5211.910.5775--8.14217,704.801.431.241.831.6622.8221.562.481.86--1.520.48440.0013.0510.64-71.42-37.6319.60--
Option Care Health Inc4.59bn211.31m5.32bn5.81k26.073.7819.451.161.191.1925.948.231.3813.2310.62790,263.806.343.637.974.3521.5522.454.602.781.367.040.44070.009.0643.4277.40--24.72--
CorVel Corp816.78m78.02m5.40bn4.87k70.0020.4551.606.614.504.5047.1315.411.81--8.98167,716.6017.2714.8730.2824.2121.7922.149.559.16----0.000.0010.685.9514.9010.5713.87--
R1 Rcm Inc2.38bn-40.00m5.99bn29.40k--2.1222.872.52-0.0956-0.09565.446.680.4393--5.8780,942.18-0.73841.35-0.79221.5320.4520.09-1.681.96--1.660.4453--24.7921.02105.21--25.07--
PACS Group Inc-100.00bn-100.00bn6.33bn32.43k--10.87----------3.75----------------------------0.4792--28.47---25.00------
Acadia Healthcare Company Inc3.06bn-5.12m7.24bn23.50k--2.4249.922.37-0.0725-0.072533.3732.210.5647--8.32179,836.800.07052.320.07922.64----0.12495.601.175.440.3754--12.208.99-107.93--3.34--
Data as of Sep 19 2024. Currency figures normalised to CorVel Corp's reporting currency: US Dollar USD

Institutional shareholders

39.90%Per cent of shares held by top holders
HolderShares% Held
Kayne Anderson Rudnick Investment Management LLCas of 30 Jun 20241.93m11.24%
BlackRock Fund Advisorsas of 30 Jun 20241.31m7.65%
The Vanguard Group, Inc.as of 30 Jun 20241.06m6.20%
Renaissance Technologies LLCas of 30 Jun 2024668.91k3.91%
Dimensional Fund Advisors LPas of 30 Jun 2024534.54k3.12%
SSgA Funds Management, Inc.as of 30 Jun 2024357.11k2.09%
Neuberger Berman Investment Advisers LLCas of 30 Jun 2024278.55k1.63%
Geode Capital Management LLCas of 30 Jun 2024244.30k1.43%
Boston Trust Walden, Inc.as of 30 Jun 2024242.54k1.42%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2024211.91k1.24%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.